Absci (ABSI) Change in Accured Expenses (2020 - 2025)

Absci (ABSI) reported Change in Accured Expenses of $2.5 million for Q3 2025, up 80.22% on a YoY basis from $1.4 million in Q3 2024, and up 22.87% sequentially from $2.0 million in Q2 2025.

Absci (ABSI) Change in Accured Expenses (2020 - 2025) Analysis & Trends

Absci (ABSI) has 6 years of Change in Accured Expenses data on file, last reported at $2.5 million in Q3 2025.

  • For the quarter ending Q3 2025, Change in Accured Expenses rose 80.22% year-over-year to $2.5 million; the trailing twelve-month figure through Sep 2025 stood at $1.9 million (up 233.87% YoY), and the FY2024 full-year result was -$295000.0, up 75.68% from the prior year.
  • Change in Accured Expenses improved to $2.5 million in Q3 2025, from $2.0 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $3.9 million in Q3 2022 to a low of -$4.5 million in Q1 2022.
  • A 5-year average of -$77947.4 and a median of -$374000.0 in 2023 frame the typical range for Change in Accured Expenses.
  • Across the five-year window, Change in Accured Expenses plunged 1337.23% in 2021 and soared 437.49% in 2022, its largest moves.
  • Tracing ABSI's Change in Accured Expenses over 5 years: stood at $2.1 million in 2021, then tumbled by 123.28% to -$500000.0 in 2022, then advanced by 25.2% to -$374000.0 in 2023, then soared by 303.21% to $760000.0 in 2024, then jumped by 230.79% to $2.5 million in 2025.
  • Business Quant data shows ABSI's Change in Accured Expenses at $2.5 million in Q3 2025, $2.0 million in Q2 2025, and -$3.4 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 66,861.65 Bn 66,861.36 Bn - 1.13 Mn
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn - -
3 Akari Therapeutics 1,071.19 Bn 1,071.19 Bn - 931,000.00
4 BeOne Medicines 469.11 Bn 464.32 Bn 1.35 Bn -16.82 Mn
5 Vertex Pharmaceuticals 123.03 Bn 115.78 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 70.13 Bn 61.37 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 63.44 Bn 63.44 Bn - -
8 Argenx Se 55.97 Bn 50.78 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn -176.03 Mn
10 Absci 1.20 Bn 1.07 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 2.51 Mn
Sep 30, 2025 2.51 Mn
Jun 30, 2025 2.05 Mn
Jun 30, 2025 2.05 Mn
Mar 31, 2025 -3.41 Mn
Mar 31, 2025 -3.41 Mn
Dec 31, 2024 760,000.00
Dec 31, 2024 760,000.00
Sep 30, 2024 1.40 Mn
Sep 30, 2024 1.40 Mn
Jun 30, 2024 1.46 Mn
Jun 30, 2024 1.46 Mn
Mar 31, 2024 -3.91 Mn
Mar 31, 2024 -3.91 Mn
Dec 31, 2023 -374,000.00
Dec 31, 2023 -374,000.00
Sep 30, 2023 2.96 Mn
Sep 30, 2023 2.96 Mn
Jun 30, 2023 -1.38 Mn
Jun 30, 2023 -1.38 Mn